Lv4
540 积分 2022-03-03 加入
Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
1天前
待确认
Advances in Targeted Therapy for Progressive Fibrosing Interstitial Lung Disease
1天前
待确认
The importance of SII and FIB-4 scores in predicting mortality in idiopathic pulmonary fibrosis patients
1天前
待确认
Real-world safety and effectiveness of pirfenidone and nintedanib in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis
1天前
待确认
Incidence, prevalence and mortality of idiopathic pulmonary fibrosis in Australia
3天前
已完结
Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial
5天前
已完结
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial
5天前
已完结
Epidemiology and real-life experience in progressive pulmonary fibrosis
7天前
已完结
Efficacy of pirfenidone and disease severity of idiopathic pulmonary fibrosis: Extended analysis of phase III trial in Japan
9天前
已完结
皖公网安备34019202002308
